Cardiovascular Health Study (CHS)

Study acronym: CHS
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 31, 2027 to Dec 31, 2027v14
  2. Primary and study completion dates pushed to Oct 31, 2027
    • Site details revised at 1 of 6 sites
    v13
  3. Study sites: 1 to 6v12
  4. Primary completion date: Dec 2023 to Aug 1, 2024v11
  5. 2 versions Re-verified since Jan 30, 2023, no change to tracked fieldsv9-v10
Show 7 earlier versionsHide 7 earlier versions
  1. Primary completion date: May 2009 to Dec 2023v8 Show 7 more changesShow less
    • Trial status: Completed to Active, Not Recruiting
    • Enrollment target: 5888
    • Study sites: 0 to 1
    • Study completion date: May 2009 to Oct 31, 2024
    • Eligibility criteria expanded, about 95 words
    • Study description shortened, about 169 words
    • Collaborators expanded, about 9 words
  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Active, Not Recruiting to Completed
    • Primary completion date: May 2009
    v6
  4. Publications: 16 to 15v5
  5. Re-verified, no change to tracked fieldsv4
  6. Study completion date: Oct 2005 to May 2009
    • Study description revised
    v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
National Heart, Lung, and Blood Institute (NHLBI)
137 trials monitored
See 6 trials at risk
Heart Disease
8,862 trials monitored
See 438 trials at risk
Diabetes
5,133 trials monitored
See 238 trials at risk
Stroke
3,558 trials monitored
See 168 trials at risk
and 2 more diseases
To determine the extent to which known risk factors predict coronary heart disease and stroke in the elderly, to assess the precipitants of coronary heart disease and stroke in the elderly, and to identify the predictors of mortality and functional impairments in clinical coronary disease or stroke.
Trial Details
NCT Number NCT00005133
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: University of Washington, the Collaborative Health Studies Coordinating Center
Conditions
(from sponsor)		 Cardiovascular Diseases, Coronary Disease, Heart Diseases, Cerebrovascular Accident, Diabetes Mellitus, Hypertension, Heart Failure, Congestive
Related terms Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Heart Failure, Hypertension, Stroke
Enrollment 5,888 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov